tiprankstipranks
Trending News
More News >
Corcept Therapeutics Inc. (CORT)
NASDAQ:CORT
US Market
Advertisement

Corcept Therapeutics (CORT) Ownership - Who Owns Corcept Therapeutics?

Compare
1,172 Followers

Corcept Therapeutics (CORT) Ownership Overview

11.45%17.35%<0.01%20.76%50.44%
11.45% Insiders
<0.01% Other Institutional Investors
20.76% ETFs
50.44% Public Companies and Individual Investors
The ownership structure of Corcept Therapeutics (CORT) stock is a mix of institutional, retail, and individual investors. Approximately 38.11% of the company’s stock is owned by Institutional Investors, 11.45% is owned by Insiders, and 50.44% is owned by Public Companies and Individual Investors.
The ownership structure of Corcept Therapeutics (CORT) stock is a mix of institutional, retail, and individual investors. Approximately 17.36% of the company’s stock is owned by Institutional Investors, 11.45% is owned by Insiders, and 20.76% is owned by Public Companies and Individual Investors.

Recent Insider Trading Activity

Date
Name
Activity
Value
Aug 26, 2025
xxxxxxxxxxxxx
$165774
Jun 18, 2025
xxxxxxxxxxxxx
$225402
May 22, 2025
xxxxxxxxxxxxx
$172862
May 20, 2025
xxxxxxxxxxxxx
$2030389

Recent Hedge Fund Trading Activity

Date
Firm
Activity
Value
Jun 30, 2025
xxxxxxxxxxxxx
$144598
Jun 30, 2025
xxxxxxxxxxxxx
$12372230
Jun 30, 2025
xxxxxxxxxxxxx
$35327787

Top Shareholders

Holder
# of Shares
Type
% Holding
Value
8,471,850Institution8.04%605,991,431
8,235,920Institution7.82%589,115,358
7,777,890Institution7.38%556,352,472
5,310,196Insider5.04%379,838,320
2,781,370Insider2.64%198,951,396
2,346,235Insider2.23%167,826,190
1,382,297Institution1.31%98,875,704
1,258,761Insider1.19%90,039,174
1,075,242Institution1.02%76,912,060
949,898Institution0.90%67,946,204

Top Mutual Fund Holders

Holder
# of Shares
Type
% Holding
Value
7,777,890Institution7.38%556,352,472
1,075,242Institution1.02%76,912,060
949,898Institution0.90%67,946,204
732,146Institution0.69%52,370,403
680,174Institution0.65%48,652,846
645,418Institution0.61%46,166,750
563,795Institution0.54%40,328,256
483,284Institution0.46%34,569,305
463,412Institution0.44%33,147,860
315,389Institution0.30%22,559,775

Top ETF Holders

Holder
# of Shares
Type
% Holding
Value
5,492,831Institution5.21%392,902,201
2,832,231Institution2.69%197,463,145
2,192,549Institution2.08%152,864,516
1,223,324Institution1.16%85,290,149
1,012,713Institution0.96%70,606,350
810,145Institution0.77%59,918,324
788,849Institution0.75%56,426,369
633,314Institution0.60%45,300,950
469,880Institution0.45%33,610,516
452,395Institution0.43%33,459,134

FAQ

Who Owns Corcept Therapeutics Inc. (CORT)?
According to the latest TipRanks data, approximately <0.01% of the company's stock is held by institutional investors, 11.45% is held by insiders, and 50.44% is held by retail investors.
    What percentage of Corcept Therapeutics Inc. (CORT) stock is held by institutional investors?
    According to the latest TipRanks data, approximately <0.01% of Corcept Therapeutics Inc. (CORT) stock is held by institutional investors.
      What percentage of Corcept Therapeutics Inc. (CORT) stock is held by retail investors?
      According to the latest TipRanks data, approximately 50.44% of Corcept Therapeutics Inc. (CORT) stock is held by retail investors.
        Who owns the most shares of Corcept Therapeutics Inc. (CORT)?
        iShares owns the most shares of Corcept Therapeutics Inc. (CORT).
          What is the significance of the ownership structure for a publicly traded company?
          The ownership structure can impact the company's decision making, as large institutional investors may exert influence on the company's management and can also affect the company's stock price with their buying and selling patterns.
            What am I Missing?
            Make informed decisions based on Top Analysts' activity
            Know what industry insiders are buying
            Get actionable alerts from top Wall Street Analysts
            Find out before anyone else which stock is going to shoot up
            Get powerful stock screeners & detailed portfolio analysis